Immutrix Therapeutics, Inc.

CIK 1656200 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Immutrix Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 22, 2025D0001093094-25-000017
Jul 14, 2020D0001656200-20-000001
Sep 5, 2019D0001656200-19-000001
Oct 12, 2018D/A0001656200-18-000001
Nov 27, 2017D0001093094-17-000005
Jul 22, 2016D/A0001656200-16-000003
Jun 28, 2016D0001656200-16-000002
Oct 20, 2015D0001656200-15-000001